BEIJING – In a new sign of the local government’s willingness to control drug costs, the tender authorities in Hunan province have stirred up a controversy and in return received pushback from some prominent national drug manufacturers’ associations.
Hunan Tender Creates Industry Jitters In China
The price slashes were so harsh that industry associations have staged a rare faceoff with authorities, with many worrying that the Hunan drug tender, being the first in the year, may herald a new round of drug price cuts in China.